Membrane expression of trail receptors DcR1 and DcR2 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer

被引：3
|
作者：
Gottwald, L. [1 ,5 ]
Pasz-Walczak, G. [2 ]
Piekarski, J. [3 ]
Szwalski, J. [7 ]
Kubiak, R. [2 ]
Spych, M. [1 ,6 ]
Suzin, J. [4 ]
Tylinski, W. [4 ]
Sek, P. [3 ]
Jeziorski, A. [3 ]
机构：
[1] Med Univ Lodz, Dept Radiotherapy, Lodz, Poland
[2] Med Univ Lodz, Dept Pathol, Lodz, Poland
[3] Med Univ Lodz, Dept Surg Oncol, Lodz, Poland
[4] Med Univ Lodz, Dept Gynecol & Gynecol Oncol, Lodz, Poland
[5] Copernicus Mem Hosp, Reg Canc Ctr, Dept Teleradiotherapy, PL-93509 Lodz, Poland
[6] Copernicus Mem Hosp, Reg Canc Ctr, Dept Radiotherapy & Gen Oncol, PL-93509 Lodz, Poland
[7] Olympus Consilio Co Ltd, Histopathol Unit, Lodz, Poland
来源：
JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2014年 / 34卷 / 04期
关键词：
DcR1; DcR2; endometrial atypical hyperplasia; endometrial cancer; immunohistochemistry; normal endometrium; TRAIL; APOPTOSIS-INDUCING LIGAND; DECOY RECEPTOR; MEMBER; FAMILY; CELLS;
D O I：
10.3109/01443615.2014.889667
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
We aimed to evaluate the membrane expression of DcR1 and DcR2 in the normal endometrium (NE), endometrial atypical hyperplasia (EAH) and endometrioid endometrial cancer (EEC). The study comprised 101 patients: 20 NE, 14 EAH and 67 EEC. Membrane expression of DcR1 and DcR2 was examined and presented as total score (TS). The membrane expression of both DcR1 and DcR2 was more common in EEC than in NE (p < 0.001; p < 0.001). A strong correlation was found between type of endometrial tissue (NE/EAH/EEC) and the TS of DcR1 (p = 0.001) and DcR2 (p = 0.001). In EEC, the TS of DcR1 and DcR2 was not related to grading and survival. The TS of DcR1 negatively correlated with staging (p = 0.018), but DcR2 did not. The membrane expression of decoy receptors for TRAIL DcR1 and DcR2 is greater in NE than EEC. In EEC patients, membrane expression of DcR1 and DcR2 are not independent predictors of survival.
引用
下载
收藏
页码：346 / 349
页数：4
相关论文
共 50 条
  • [21] Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study
    Samani, Simin Mirakhor
    Bojnordi, Tahmineh Ezazi
    Zarghampour, Manijeh
    Merat, Sobhan
    Fouladi, Daniel F.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 38 (07) : 999 - 1004
  • [22] Cell proliferation, programmed cell death and Bcl-2 expression in normal endometrium, endometrial hyperplasia and endometrial carcinoma.
    Mora, LB
    Nicosia, SV
    Cantor, A
    Diez, JI
    LABORATORY INVESTIGATION, 1997, 76 (01) : 611 - 611
  • [23] Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group
    Gungorduk, Kemal
    Ertas, Ibrahim Egemen
    Sahbaz, Ahmet
    Ozvural, Seyfettin
    Sarica, Yagmur
    Ozdemir, Aykut
    Sayhan, Sevil
    Gokcu, Mehmet
    Yilmaz, Bulent
    Sanci, Muzaffer
    Inan, Sevinc
    Harma, Mehmet
    Yildirim, Yusuf
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 179 : 147 - 152
  • [24] Characterization of Mig-6 expression in normal and PCOS endometrium suggests a mechanism for endometrial hyperplasia and cancer.
    Lessey, Bruce A.
    Young, Steven L.
    Larson, Sandra F.
    DeMayo, Francesco J.
    Jeong, Jawook
    Savaris, Ricardo F.
    Giudice, Linda C.
    REPRODUCTIVE SCIENCES, 2008, 15 (02) : 316A - 317A
  • [25] Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis
    Quddus, MR
    Latkovich, P
    Castellani, WJ
    Sung, CJ
    Steinhoff, MM
    Briggs, RC
    Miranda, RN
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2002, 126 (04) : 459 - 463
  • [26] Expression of Estrogen Receptors (α, β), Cyclooxygenase-2 and Aromatase in normal endometrium and endometrioid cancer of uterus
    Knapp, P.
    Chabowski, A.
    Blachnio-Zabielska, A.
    Walentowicz-Sadlecka, M.
    Grabiec, M.
    Knapp, P. A.
    ADVANCES IN MEDICAL SCIENCES, 2013, 58 (01): : 96 - 103
  • [27] Microsatellite instability and immunohistochemical analysis of MLH1 and MSH2 in normal endometrium, endometrial hyperplasia and endometrial cancer from a hereditary nonpolyposis colorectal cancer patient
    Ichikawa, Y
    Tsunoda, H
    Takano, K
    Oki, A
    Yoshikawa, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (03) : 110 - 112
  • [28] HCG modulates HMGB1 and RAGE expression in normal human endometrium and in endometrial cancer
    Zicari, A.
    Mari, E.
    Ticconi, C.
    Bruno, V
    Patrizi, L.
    Rasi, V
    Vizza, E.
    Piccione, E.
    PLACENTA, 2013, 34 (02) : A18 - A18
  • [29] Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma
    Hamid, AA
    Mandai, M
    Konishi, I
    Nanbu, K
    Tsuruta, Y
    Kusakari, T
    Kariya, M
    Kita, M
    Fujii, S
    CANCER, 2002, 94 (04) : 997 - 1005
  • [30] Expression of Cyclin D1 in normal, metaplastic, hyperplastic endometrium, and endometrioid carcinoma suggests a role for endometrial carcinogenesis.
    Quddus, MR
    Latkovich, P
    Castellani, WC
    Sung, CJ
    Steinhoff, MM
    Mirnada, RN
    LABORATORY INVESTIGATION, 2001, 81 (01) : 144A - 144A
12345